Kamal Sahlani
Internal Medicine · Euclid, OHNPI 1669456562
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $796 and has fallen 80.4% since, to $156 in 2023.
Across 145 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$292
- Boehringer Ingelheim$217
- Lilly USA, LLC$205
- Amgen$184
- AbbVie$174
- Novo Nordisk$168
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,273100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $292 |
| Boehringer Ingelheim | 14 | $217 |
| Lilly USA, LLC | 13 | $205 |
| Amgen | 11 | $184 |
| AbbVie(2 entities) | 9 | $174 |
| Novo Nordisk | 12 | $168 |
| Merck | 7 | $107 |
| Nestle Healthcare Nutrition Inc. | 6 | $102 |
| Pfizer | 6 | $98 |
| Novartis | 5 | $86 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| Abbott | 4 | $73 |
| Amarin Pharma, Inc. | 4 | $62 |
| Grifols USA, LLC | 4 | $60 |
| Johnson & Johnson | 4 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $51 |
| Radius Health, Inc. | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $27 |
| GSK | 2 | $26 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Seqirus USA Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$2,273 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Euclid
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.